Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Severin Schwan
Age : 54
Public asset : 83,458,984 USD
Country of residence : Unknown
Linked companies : Roche Holding AG

Biography of Severin Schwan 
Dr. Severin Schwan is a Vice President at International Federation of Pharmaceutical Manufacturers, a Vice Chairman at Credit Suisse Group AG, a Member of the Board of Directors at Credit Suisse AG, a Member at European Round Table of Industrialists, a Member at International Business Leaders Advisory Council, a Chairman at Roche Holdings, Inc., a Chief Executive Officer at Roche Group, a Chief Executive Officer & Executive Director at Roche Holding AG, a Chief Executive Officer & Director at F. Hoffmann-La Roche Ltd., a Chairman at Genentech, Inc., a Chairman at Roche Pharma Schweiz AG, a Chairman-Supervisory Board at Roche Diabetes Care GmbH, a Chairman-Supervisory Board at Roche Diagnostics Deutschland GmbH and a Chairman-Supervisory Board at Roche Pharma AG. He is on the Board of Directors at Credit Suisse Group AG, Credit Suisse AG, Roche Holding AG and F. Hoffmann-La Roche Ltd. Dr. Schwan was previously employed as a Chief Executive Officer by Roche Diagnostics Corp., a Head-Asia Pacific Region by Roche Diagnostics Asia Pacific Pte Ltd., a Head-Global Finance & Services by Roche Diagnostics AG, a Member-Executive Board by Roche Deutschland Holding GmbH, a Head-Finance & Administration by Roche (Brussels), and a Chairman-Member-Supervisory Board by Roche Diagnostics GmbH. He also served on the board at Credit Suisse (Schweiz) AG and Chugai Pharmaceutical Co., Ltd. He received his graduate degree from the University of Innsbruck and a doctorate degree from the University of Innsbruck.


Current positions of Severin Schwan 
Holdings of Severin Schwan 
Severin Schwan : Personal Network 
Most Read News 
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
12/06The rise and fall of Wirecard
RE
12/09China's Li Auto sees higher deliveries in Q4; third-quarter loss widens
RE
12/06Billionaire Forrest aims to develop 5 GW of wind farms by 2030
RE
11/29Ryanair's O'Leary says industry most optimistic in 25 years
RE
11/25Elon Musk says Twitter's ban on Trump after Capitol attack was 'grave mistake'
RE
11/28Leon Black accused in lawsuit of raping woman in Jeffrey Epstein's mansion
RE
More news


© 2022 People and Ownership :   
Severin Schwan : Connections 


Latest news about Severin Schwan 
11/14Roche's Alzheimer's drug fails to meet goal in long awaited trial
RE
11/14Roche's Alzheimer's drug fails to meet goal in long awaited trial
RE
10/18Transcript : Roche Holding AG, Q3 2022 Sales/ Trading Statement Call, Oct 18, 2022
CI
10/18Roche's Alzheimer's Disease Drug Candidate Put Under Spotlight After Q3 Sales Dip
MT
09/12Transcript : Roche Holding AG - Special Call
CI
07/21Transcript : Roche Holding AG, H1 2022 Earnings Call, Jul 21, 2022
CI
07/21Roche Maintains Full-Year Targets Despite Diminishing Sales Boost from COVID-19 Diagnostics, Medicines
MT
More news